143 related articles for article (PubMed ID: 22143340)
1. Aortitis in a patient with psoriatic arthritis.
Tufan A; Engin Tezcan M; Kaya A; Mercan R; Oner Y; Ozturk MA
Mod Rheumatol; 2012 Sep; 22(5):774-7. PubMed ID: 22143340
[TBL] [Abstract][Full Text] [Related]
2. Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.
Kavanaugh A; Tutuncu Z; Catalan-Sanchez T
Curr Opin Rheumatol; 2006 Jul; 18(4):347-53. PubMed ID: 16763453
[TBL] [Abstract][Full Text] [Related]
3. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
4. Etanercept: new indication. For ankylosing spondylitis: another option.
Prescrire Int; 2005 Jun; 14(77):92-3. PubMed ID: 15981387
[TBL] [Abstract][Full Text] [Related]
5. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.
Delaunay C; Farrenq V; Marini-Portugal A; Cohen JD; Chevalier X; Claudepierre P
J Rheumatol; 2005 Nov; 32(11):2183-5. PubMed ID: 16265699
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical reaction to etanercept: development of pyoderma gangraenosum during therapy of psoriasis arthritis.
Kowalzick L; Bertolini J; Baumann C; Walther B; Truhm B; Eickenscheidt L
J Dtsch Dermatol Ges; 2013 May; 11(5):447-9. PubMed ID: 23343137
[No Abstract] [Full Text] [Related]
7. [Treatment of psoriatic arthritis with TNF alpha-antagonists].
Antoni C; Manger B
Z Rheumatol; 2003 Jun; 62(3):235-9. PubMed ID: 12827399
[TBL] [Abstract][Full Text] [Related]
8. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
Benucci M; Nenci G; Cappelletti C; Manfredi M
Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
[TBL] [Abstract][Full Text] [Related]
9. Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists.
Fernández-Nebro A; Tomero E; Ortiz-Santamaría V; Castro MC; Olivé A; de Haro M; Portales RG; González-Mari MV; Laffón A; García-Vicuña R
Am J Med; 2005 May; 118(5):552-6. PubMed ID: 15866260
[No Abstract] [Full Text] [Related]
10. Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings.
Bonafede M; Fox KM; Watson C; Princic N; Gandra SR
Adv Ther; 2012 Aug; 29(8):664-74. PubMed ID: 22886712
[TBL] [Abstract][Full Text] [Related]
11. Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis.
Girolomoni G; Altomare G; Ayala F; Berardesca E; Calzavara-Pinton P; Chimenti S; Peserico A; Puglisi Guerra A; Vena GA
Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):548-60. PubMed ID: 22296031
[TBL] [Abstract][Full Text] [Related]
12. Arthralgia as an adverse event to infliximab: a reactive arthritis or triggering of psoriatic arthritis? Successful management by switching to etanercept.
Moustou AE; Stratigos AJ; Vergou T; Gregoriou S; Georgala S; Danopoulou I
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):968-9. PubMed ID: 19207660
[No Abstract] [Full Text] [Related]
13. Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept.
Costa L; Atteno M; Caso F; Scarpato L; Del Puente A; Scarpa R
Int J Rheum Dis; 2014 Feb; 17(2):219-20. PubMed ID: 24576280
[No Abstract] [Full Text] [Related]
14. Etanercept is safely used for treating psoriatic arthritis in a patient complicated with type 1 hereditary angioedema.
Umegaki N; Kira M; Horiuchi T; Itoi S; Tani M; Yokomi A; Tanemura A; Miyahara H; Hatanaka M; Kitamura H; Kitano E; Katayama I
Mod Rheumatol; 2012 Nov; 22(6):928-30. PubMed ID: 22310967
[TBL] [Abstract][Full Text] [Related]
15. Cost per treated patient for etanercept, adalimumab, and infliximab across adult indications: a claims analysis.
Bonafede MM; Gandra SR; Watson C; Princic N; Fox KM
Adv Ther; 2012 Mar; 29(3):234-48. PubMed ID: 22411424
[TBL] [Abstract][Full Text] [Related]
16. Psoriatic arthritis patients doing better on infliximab than etanercept.
Smith N; Gadsby K; Deighton C
Rheumatology (Oxford); 2007 Apr; 46(4):721-2. PubMed ID: 17314216
[No Abstract] [Full Text] [Related]
17. Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.
D'Angelo S; Cutro MS; Lubrano E; Leccese P; Mennillo GA; Ferrara N; Olivieri I
Ann Rheum Dis; 2010 May; 69(5):934-5. PubMed ID: 19666936
[No Abstract] [Full Text] [Related]
18. Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study.
Modesti V; Ramonda R; Ortolan A; Lorenzin M; Lo Nigro A; Frallonardo P; Oliviero F; Campana C; Punzi L
Scand J Rheumatol; 2012; 41(6):490-1. PubMed ID: 22985209
[No Abstract] [Full Text] [Related]
19. Melkersson-Rosenthal syndrome in a patient with psoriatic arthritis receiving etanercept.
Gaudio A; Corrado A; Santoro N; Maruotti N; Cantatore FP
Int J Immunopathol Pharmacol; 2013; 26(1):229-33. PubMed ID: 23527726
[TBL] [Abstract][Full Text] [Related]
20. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
[Next] [New Search]
